Innovate Biopharmaceuticals Inc. named June Almenoff as its chief medical officer and COO.
Almenoff is joining Innovate from RDD Pharma, a privately held gastrointestinal clinical-stage biopharma company, where she has been the chairperson since 2015.
She also served as president and chief medical officer of Furiex Pharmaceuticals Inc., a drug development company acquired by Allergan PLC in 2014.
Almenoff will lead the development of Innovate's pipeline including the upcoming phase 3 program for celiac disease.
Innovate Biopharmaceuticals is a Raleigh, N.C.-based clinical biotechnology company focused on developing autoimmune and inflammation therapeutics.
